Sources | Names Used |
---|---|
CTRPv2 | SR-II-138A |
PharmacoGx | SR-II-138A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD109 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
mRNA | CALU | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-07 |
mRNA | S100A6 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
mRNA | GPHN | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | PRNP | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
mRNA | AMELX | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-07 |
mRNA | SRPX2 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
mRNA | S100A10 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
mRNA | TAF5 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | ITGB5 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |